Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
Urinary excretion of 5-S-cysteinyldopa (5-S-CD) was followed in 20 patients receiving PUVA therapy. Large increases were observed after PUVA treatment, more predominant in males and unrelated to skin types. Relative increases rather than absolute values paralleled cutaneous reactions.
D000328:Adult; D003548:Cysteinyldopa / Q000652:urine*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D008730:Methoxsalen / Q000494:pharmacology*; D011701:PUVA Therapy / Q000009:adverse effects; D012737:Sex Factors; D012879:Skin Physiological Phenomena
D003548:Cysteinyldopa; D004295:Dihydroxyphenylalanine; D008730:Methoxsalen